The ASCO Post

: Precision oncology isn't just about selecting the right therapy. It's ensuring patients receive guideline-concordant care.

At , Annabelle Fonseca, MD, MHS, of UAB Medicine, discussed how machine learning and electronic health record data were used to identify patients with pancreatic cancer who may be at risk for treatment deviations.

A promising application of AI to improve care delivery and patient outcomes.

https://ascoai.org/videos/newsreels/2026/machine-learning-identifies-non-guideline-concordant-treatment-in-pancreatic-cancer/